NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Cantaloupe, Inc. (“Cantaloupe” or the “Company”) CTLP.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Flagstar Bancorp, Inc. (“Flagstar” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating allegations on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of Hannon Armstrong Sustainable Infrastructure Capital, Inc. (“Hannon” or
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Sunrun Inc. (“Sunrun” or the “Company”) (NASDAQ:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Enviva, Inc. (“Enviva” or the “Company”) Eve.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Block, Inc. (“Block” or the “Company”) Q.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Block, Inc. (“Block” or the “Company”) (NYSE:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Barclays PLC (“Barclays” or the “Company”) UCS.
NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Compass Minerals International, Inc. (“Compass” or the
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Cantaloupe, Inc. (“Cantaloupe” or the “Company”) CTLP.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Avidity Biosciences, Inc. (“Avidity” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Flagstar Bancorp, Inc. (“Flagstar” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating allegations on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of Hannon Armstrong Sustainable Infrastructure Capital, Inc. (“Hannon” or
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Sunrun Inc. (“Sunrun” or the “Company”) (NASDAQ:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Enviva, Inc. (“Enviva” or the “Company”) Eve.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”)
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Block, Inc. (“Block” or the “Company”) Q.
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Block, Inc. (“Block” or the “Company”) (NYSE:
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Barclays PLC (“Barclays” or the “Company”) UCS.
